HISUN(SH:600267)2022-04-25 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥2,977,204,828.98, representing a decrease of 2.96% compared to the same period last year[6] - Net profit attributable to shareholders of the listed company was ¥135,128,838.42, an increase of 7.48% year-on-year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥113,675,449.19, reflecting a growth of 23.12% compared to the previous year[6] - Basic earnings per share were ¥0.113, down by 7.38% compared to the same period last year[9] - The diluted earnings per share were also ¥0.113, a decrease of 5.04% year-on-year[9] - The weighted average return on equity was 1.83%, a decrease of 0.02 percentage points compared to the end of the previous year[9] - Total operating revenue for Q1 2022 was CNY 2,977,204,828.98, a decrease of 2.94% from CNY 3,067,936,076.77 in Q1 2021[28] - Net profit for Q1 2022 was CNY 135,971,298.82, a decline of 27.67% compared to CNY 187,817,286.10 in Q1 2021[33] - Basic earnings per share for Q1 2022 were CNY 0.113, compared to CNY 0.122 in Q1 2021[33] Cash Flow - The net cash flow from operating activities was ¥286,573,768.25, which increased by 24.48% year-on-year[6] - In Q1 2022, the net cash flow from operating activities was RMB 286,573,768.25, an increase of 24.5% compared to RMB 230,216,190.84 in Q1 2021[37] - Total cash inflow from operating activities was RMB 3,093,611,140.36, slightly down from RMB 3,137,070,881.37 in the same period last year[37] - Cash outflow for purchasing goods and services decreased to RMB 1,428,610,584.88 from RMB 1,550,713,484.04, reflecting a reduction of approximately 7.9%[37] - The net cash flow from investment activities was -RMB 241,899,741.78, an improvement from -RMB 1,129,143,745.14 in Q1 2021[39] - Cash inflow from financing activities totaled RMB 1,879,183,564.45, down from RMB 3,159,071,072.34 in the previous year[39] - The net cash flow from financing activities was RMB 194,941,690.12, compared to a negative cash flow of -RMB 144,622,837.30 in Q1 2021[39] - The ending balance of cash and cash equivalents increased to RMB 1,417,960,646.07 from RMB 965,348,391.74 year-over-year[39] Assets and Liabilities - Total assets at the end of the reporting period were ¥19,466,613,801.76, an increase of 0.48% from the end of the previous year[9] - Total liabilities amounted to RMB 8,598,631,964.63, a decrease from RMB 8,784,874,258.87, indicating a reduction of approximately 2.1%[26] - Short-term borrowings increased to RMB 4,235,665,795.27 from RMB 3,988,480,542.46, reflecting an increase of about 6.2%[26] - The company’s total assets reached RMB 19,466,613,801.76, up from RMB 19,374,263,488.94, marking a growth of approximately 0.5%[26] - The company’s non-current assets totaled RMB 12,930,731,226.14, down from RMB 13,010,278,485.52, indicating a decrease of about 0.6%[26] - The company reported a total debt of CNY 11,971,822,231.84, slightly down from CNY 12,028,750,319.54 in the previous period[28] - The total equity attributable to shareholders of the parent company increased to CNY 7,451,679,352.40 from CNY 7,303,284,714.25[28] Current Assets - The company reported a total current assets of RMB 6,535,882,575.62 as of March 31, 2022, an increase from RMB 6,363,985,003.42 as of December 31, 2021, reflecting a growth of approximately 2.7%[23] - Cash and cash equivalents increased to RMB 1,557,075,825.25 from RMB 1,295,750,258.65, representing a growth of about 20.2% year-over-year[23] - Accounts receivable rose to RMB 2,187,692,242.08 from RMB 2,092,921,220.08, indicating an increase of approximately 4.5%[23] - Inventory decreased to RMB 1,807,947,933.14 from RMB 2,022,881,414.99, showing a decline of about 10.6%[23] Investments and Subsidiaries - The company plans to invest RMB 5 million to establish a marketing subsidiary in Beijing, which has been registered with a capital of RMB 5 million[19] - The company approved a capital increase of no less than RMB 60 million for its subsidiary, Zhejiang Haizheng Sulikang Biotechnology Co., with a pre-investment valuation of no less than RMB 137,220,000[20] Other Comprehensive Income - Other comprehensive income after tax for Q1 2022 was CNY 162,875.02, compared to a loss of CNY 15,028,565.70 in Q1 2021[33] Expenses - Total operating costs for Q1 2022 were CNY 2,773,861,709.12, down from CNY 2,836,451,451.06 in Q1 2021[32] - R&D expenses for Q1 2022 amounted to CNY 83,286,810.37, an increase from CNY 77,093,297.90 in Q1 2021[32] - The company experienced a decrease in sales expenses to CNY 537,528,642.73 from CNY 559,060,778.31 in the previous year[32] - Cash outflow for employee compensation increased to RMB 582,098,001.55 from RMB 543,204,185.21, reflecting a rise of approximately 7.1%[37] Tax Refunds - The company received tax refunds amounting to RMB 13,716,664.15, an increase from RMB 11,398,182.33 in the same quarter last year[37]